Delisted
No longer trades. Fund positions are valued at its last close, $17.03 on Sep 23, 2026. View SEC filing

THERAVANCE BIOPHARMA INC
TBPHHealthcare
TBPH (THERAVANCE BIOPHARMA INC) is held by 1 institutional investors as of Q3 2026. Top institutional shareholders: Glenmede Trust Co. N.A. ($9,329).
No verdict yet — fewer than 2 funds hold TBPH.
Top Holders
Fund ownership
Fund holdings as of
Funds holding1
Value of reported holdings$9,329
Funds buying / selling
Not available
Checking access…
Showing 1-20 of 113
1 / 6
| Insider | Trade | Traded |
|---|---|---|
| Winningham Rick E | Disp | |
| Miller Aine | Disp | |
| Sawaf Aziz | Disp | |
| Grimaud Brett A. | Disp | |
| Grimaud Brett A. | Disp | |
| Winningham Rick E | Disp | |
| Weiss Asset Management LP | Other 7.5M sh | |
| Samaha Eli | Other 9.2M sh | |
| Sawaf Aziz | Disp | |
| Farnum Rhonda | Disp |
Loading Congress trades…
| Filer | Stake | Filed |
|---|---|---|
| Newtyn Management, LLC | 0.0% | |
| Madison Avenue International LP | 0.0% | |
| Weiss Asset Management LP | 0.0% | |
| Newtyn Management, LLC | 6.7% | |
| Madison Avenue International LP | 17.7% | |
| Weiss Asset Management LP | 14.5% | |
| Newtyn Management, LLC | 8.5% | |
| BlackRock, Inc. | 6.5% |
Continue exploring
Other Healthcare stocks held by institutions
456 holders · $264.6B
455 holders · $846.2B
442 holders · $208.3B
438 holders · $117B
437 holders · $430.7B
432 holders · $256.6B
425 holders · $314.1B
425 holders · $109.3B
418 holders · $123.6B
412 holders · $151.2B
Questions investors ask about TBPH
Who owns TBPH?
1 institutional investor held TBPH on September 30, 2026, led by Glenmede Trust Co. N.A. ($9,329).
How many hedge funds hold TBPH?
1 institutional investor reported TBPH in their 13F filings for the quarter ended September 30, 2026, $9,329 in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer